April 2024 Federal Circuit Newsletter (Japanese) April 2024 Federal Circuit Newsletter (Chinese) Obviousness Analysis Does Not Consider Unclaimed Limitations In Janssen Pharmaceuticals, Inc. v. Teva Pharmaceuticals Usa, Inc., Appeal No….
March 2024 Federal Circuit Newsletter (Japanese) March 2024 Federal Circuit Newsletter (Chinese) Defining Indefiniteness: When Are Claim Limitations Contradictory? In Maxell, Ltd., v. Amperex Technology Limited, Appeal No. 23-1194,…
February 2024 Federal Circuit Newsletter (Japanese) February 2024 Federal Circuit Newsletter (Chinese) The Outcome of the PTAB’s Analysis May Determine Whether the PTAB Engaged in Claim Construction In Google LLC…
January 2024 Federal Circuit Newsletter (Japanese) January 2024 Federal Circuit Newsletter (Chinese) Single Means Single In Pacific Biosciences Of California, Inc. v. Personal Genomics Taiwan, Inc., Appeal No. 22-1410,…
December 2023 Federal Circuit Newsletter (Japanese) December 2023 Federal Circuit Newsletter (Chinese) Intel Wrongly Denied Opportunity to Litigate License Defense that Could Unwind $2.1 Billion Judgment In Vlsi Technology…
November 2023 Federal Circuit Newsletter (Japanese) November 2023 Federal Circuit Newsletter (Chinese) Federal Circuit Orders District Court to Consider Extrinsic Evidence in Claim Construction In Actelion Pharmaceuticals Ltd. v….
October 2023 Federal Circuit Newsletter (Japanese) October 2023 Federal Circuit Newsletter (Chinese) Substantial Evidence in Determining Obviousness In Schwendimann v. Neenah, Inc, Appeal No. 22-1335, the Federal Circuit held that…
August 2023 Federal Circuit Newsletter (Japanese) August 2023 Federal Circuit Newsletter (Chinese) IPR Petitioners Must Be Permitted to Respond to Claim Constructions First Proposed in Patent Owner Response In Axonics,…
July 2023 Federal Circuit Newsletter (Japanese) July 2023 Federal Circuit Newsletter (Chinese) Can’t Stop a Bull: Limits of Claim Preclusion In Inguran, LLC Dba Stgenetics v. Abs Global, Inc.,…
June 2023 Federal Circuit Newsletter (Japanese) June 2023 Federal Circuit Newsletter (Chinese) Objective Evidence in Determining Obviousness In Medtronic, Inc. v. Teleflex Innovations, Appeal No. 21-2357, the Federal Circuit held…
